Skip to content
TrialScanner

NCT05741346

Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria

Phase 2TerminatedBCRXLead

Registry record

Lead sponsor
BioCryst Pharmaceuticals
Conditions
Paroxysmal Nocturnal Hemoglobinuria
Primary completion
Jan 31, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05741346 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.